EU MDR Labelling compliance: Learning the lessons from UDI

The European medical device industry is in the grip of the biggest changes the market has seen in decades: the European Medical Device Regulation. These new rules to ensure the safety of medical devices became active in June 2017, imposing major new requirements on anybody involved in the design, manufacture, approval and commercialization of devices that are sold in the EU.
The final directive aims to establish a robust, transparent, predictable and sustainable regulatory framework allowing the ability to trace a device from its manufacturer through the supply chain to the final end user. This whitepaper shows the significant ramifications the regulation will have on labelling operations.
Click here to read the whitepaper EU MDR Labeling Compliance: Learning the Lessons from UDI by PRISYM ID and Be4Ward (registration required).
Click here for more information about the NVC project Pharmaceutical Packaging Innovation.
Click here for more information about the Live Online NVC E-Course Pharmaceutical Packaging.

This news item is also included in our monthly overview, the NVC Members-only Update. If you have any questions, please contact us: info@nvc.nl, +31-(0)182-512411.